On Invalid Date, Integra Lifesciences Holdings (NASDAQ: IART) reported Q4 2023 earnings per share (EPS) of $0.26, up 59.38% year over year. Total Integra Lifesciences Holdings earnings for the quarter were $19.83 million. In the same quarter last year, Integra Lifesciences Holdings's earnings per share (EPS) was $0.64.
As of Q2 2024, Integra Lifesciences Holdings's earnings has grown -61.01% year over year. This is 148.88 percentage points lower than the US Medical Devices industry earnings growth rate of 87.87%. Integra Lifesciences Holdings's earnings in the past year totalled $67.74 million.
What is IART's earnings date?
Integra Lifesciences Holdings's earnings date is Invalid Date. Add IART to your watchlist to be reminded of IART's next earnings announcement.
What was IART's revenue last quarter?
On Invalid Date, Integra Lifesciences Holdings (NASDAQ: IART) reported Q4 2023 revenue of $397.04 million up 0.25% year over year. In the same quarter last year, Integra Lifesciences Holdings's revenue was $398.02 million.
What was IART's revenue growth in the past year?
As of Q2 2024, Integra Lifesciences Holdings's revenue has grown -1.03% year over year. This is 10.42 percentage points lower than the US Medical Devices industry revenue growth rate of 9.39%. Integra Lifesciences Holdings's revenue in the past year totalled $1.54 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.